Log inSign up
AAOIFI No. 21 screening

Is ADRX halal?

ADARx Pharmaceuticals, Inc.

Not halal

ADARx Pharmaceuticals, Inc. did not pass AAOIFI screening. The failed check is shown below.

Checked: 15 October 2026

Exchange

NASDAQ

Price

17.65

Day

-0.28%

Market cap

$1.92B

Industry

Biotechnology

Sector

Healthcare

What the company does

ADARx Pharmaceuticals is a clinical-stage biotech developing siRNA (gene-silencing) drugs: three clinical programs for complement-mediated diseases, hereditary angioedema and thrombosis, plus early programs in obesity and Alzheimer's. No commercial product or revenue; funded by investors (September 2026 IPO).

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $6.90M ÷ current market cap $1.92B = 0.4%

    0.4%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $427.25M ÷ current market cap $1.92B = 22.2%

    22.2%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    Interest income $13.64M ÷ annual revenue $3.45M (2025) = 395.5%

    395.5%

    Fail

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict.

In the lists

In the S&P 500
Not in the S&P 500

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.